The methylation of p16INK4a has been shown to be important in tumour development in several tissue types, such as the colon, lung, head and neck, pancreas, cervix, large bowel, leukemia and lymphoma but is seemingly not important in ovarian cancer [34-36]. The gene discussed is CDKN2A; the disease is leukemia.